C57BL/6JCya-S100a7aem1flox/Cya
Common Name:
S100a7a-flox
Product ID:
S-CKO-10948
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
S100a7a-flox
Strain ID
CKOCMP-381493-S100a7a-B6J-VA
Gene Name
Product ID
S-CKO-10948
Gene Alias
Gm1020; S100A7L1; S100A7f; S100a15; S100a15a; S100a17l1
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
3
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-S100a7aem1flox/Cya mice (Catalog S-CKO-10948) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000079286
NCBI RefSeq
NM_199422
Target Region
Exon 2
Size of Effective Region
~1.0 kb
Detailed Document
Overview of Gene Research
S100a7a, a member of the S100 protein family, is involved in various biological processes such as innate immunity, antimicrobial function, and epithelial tumorigenesis [6]. It has been associated with multiple disease conditions, highlighting its significance in biological systems.
In acne vulgaris patients, isotretinoin therapy downregulates the S100a7a peptide mean level, suggesting its potential as a target for acne treatment [1]. In renal fibrosis, overexpressing S100A7a in proximal tubular cells impairs fatty acid oxidation and promotes lipid peroxidation, exacerbating renal fibrosis. Specific deletion of S100a7a in tubular cells enhances fatty acid oxidation, reduces lipid peroxidation, and alleviates renal fibrosis [2]. In rosacea, the upregulation of S100A7A may be involved in the pathogenesis of the disease [3]. In FLT3-ITD-positive acute myeloid leukemia, the promoting effects of circ_0000370 on the disease progression might be related to the upregulation of S100A7A [4]. In ovarian cancer patients, the up-regulation of S100A7A has been demonstrated [5]. In pigs, S100A7A is expressed at the maternal-conceptus interface at the initiation of implantation in response to conceptus-derived estrogen and IL1B [6]. In oral squamous cell carcinoma, S100A7A might be a downstream target of BEX4, which functions as a tumor suppressor [7]. In head and neck squamous cell carcinoma, high mRNA expression levels of S100A7A are related to a good overall survival [8,9].
In conclusion, S100a7a plays diverse roles in various biological processes and disease conditions. Studies, including those using potential gene-knockout models in some cases, have provided insights into its functions in acne, renal fibrosis, rosacea, leukemia, ovarian cancer, conceptus implantation, oral and head-neck cancers. These findings contribute to understanding the biological functions of S100a7a and its implications in disease development and treatment.
References:
1. Al-Sudany, Nameer K, Mohammed, Nadia H, Alrifai, Sinan B. 2019. Downregulation of S100a7a antimicrobial peptide in acne vulgaris patients after isotretinoin therapy. In Dermatologic therapy, 32, e13136. doi:10.1111/dth.13136. https://pubmed.ncbi.nlm.nih.gov/31639246/
2. Sun, Pengxiao, Chen, Qingzhou, Chen, Xiaomei, Wu, Qiaoyuan, Nie, Jing. 2025. Renal tubular S100A7a impairs fatty acid oxidation and exacerbates renal fibrosis via both intracellular and extracellular pathway. In Biochimica et biophysica acta. Molecular basis of disease, 1871, 167656. doi:10.1016/j.bbadis.2025.167656. https://pubmed.ncbi.nlm.nih.gov/39778778/
3. Barraza, Gustavo Adolfo, Castro-Guijarro, Ana Carla, de la Fuente Hoffmann, Valentina, Flamini, Marina Inés, Sanchez, Angel Matias. 2024. Drug repositioning for rosacea disease: Biological TARGET identification, molecular docking, pharmacophore mapping, and molecular dynamics analysis. In Computers in biology and medicine, 181, 108988. doi:10.1016/j.compbiomed.2024.108988. https://pubmed.ncbi.nlm.nih.gov/39168013/
4. Zhang, Lingyan, Bu, Zibin, Shen, Juan, Chen, Yuanyuan, Wang, Yan. 2019. A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 122, 109619. doi:10.1016/j.biopha.2019.109619. https://pubmed.ncbi.nlm.nih.gov/31919040/
5. Maděrka, M, Pilka, R, Neubert, D, Hambálek, J. . New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology. In Ceska gynekologie, 84, 303-308. doi:. https://pubmed.ncbi.nlm.nih.gov/31818115/
6. Lee, Soohyung, Jang, Hwanhee, Yoo, Inkyu, Jung, Wonchul, Ka, Hakhyun. 2019. Unique epithelial expression of S100A calcium binding protein A7A in the endometrium at conceptus implantation in pigs. In Asian-Australasian journal of animal sciences, 32, 1355-1362. doi:10.5713/ajas.18.0920. https://pubmed.ncbi.nlm.nih.gov/30744322/
7. Gao, Wei, Li, John Zeng-Hong, Chen, Si-Qi, Chan, Jimmy Yu-Wai, Wong, Thian-Sze. 2016. Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma. In Journal of experimental & clinical cancer research : CR, 35, 92. doi:10.1186/s13046-016-0355-6. https://pubmed.ncbi.nlm.nih.gov/27297407/
8. Gao, Shuo, Zhang, Hao, Lai, Linbin, Qian, Airong, Zhang, Wenjuan. 2022. S100A10 might be a novel prognostic biomarker for head and neck squamous cell carcinoma based on bioinformatics analysis. In Computers in biology and medicine, 149, 106000. doi:10.1016/j.compbiomed.2022.106000. https://pubmed.ncbi.nlm.nih.gov/36049414/
9. Bai, Guo, Yue, Shijing, You, Yuanhe, Zhang, Zhiyuan, Yang, Chi. 2023. An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma. In Translational cancer research, 12, 717-731. doi:10.21037/tcr-22-1353. https://pubmed.ncbi.nlm.nih.gov/37180672/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen